Nicole Le Corre,Constanza Martínez-Valdebenito,Carolina Henriquez et al.
Nicole Le Corre et al.
Preparing Europe for imported Andes virus: the role of rapid serology and molecular diagnostics [0.03%]
为欧洲输入的安第斯病毒疫情做准备：快速血清学和分子诊断的作用
Thirumalaisamy P Velavan,Jonas Schmidt-Chanasit
Thirumalaisamy P Velavan
Estimating the Potential Burden of Clinically Significant Hantavirus Cases in Argentina [0.03%]
阿根廷临床显著汉坦病毒病例潜在负担的估计
Younjung Kim,Christl A Donnelly
Younjung Kim
Junwen Guo,Jan C Semenza
Junwen Guo
Leonie Kraft,Joerg Latus
Leonie Kraft
From Ebola to Hantavirus: Spain's Preparedness for High-Consequence Infectious Diseases [0.03%]
从埃博拉到汉坦病毒：西班牙应对高后果传染病的准备情况
Elizabeth Diago-Navarro,Claudia García-Vaz,Gonzalo Fanjul et al.
Elizabeth Diago-Navarro et al.
The hantavirus outbreak linked to the MV Hondius cruise ship, managed by Spanish authorities in May 2026, provides a timely opportunity to examine how Spain prepares and responds to imported high-consequence infectious diseases (HCID). This...
Beyond pathogen-specific preparedness: adaptable laboratory systems for emerging infections [0.03%]
超越特定病原体的准备性：适应新发传染病的实验系统
María Paz Sánchez-Seco,Gustavo Palacios
María Paz Sánchez-Seco
Allocation Mechanisms of the European Asylum, Migration and Integration Fund in Germany Raises Concerns [0.03%]
欧盟在德国的 asylum, migration and integration 基金分配机制令人担忧
Andreas W Gold,Kayvan Bozorgmehr
Andreas W Gold
Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial [0.03%]
免疫吸附与假治疗对后新冠肺炎综合症疗效的比较：一项随机假对照交叉试验
Marco Stortz,Andreas Kommer,Myriam Meineck et al.
Marco Stortz et al.
Background: Post-Covid syndrome is a debilitating condition which may be caused and/or aggravated by autoantibodies. The current study aimed to determine whether autoantibody depletion by immunoadsorption is effective to ...
Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors Among Patients with Type 1 Diabetes: A Nationwide Register-Based Cohort Study [0.03%]
1型糖尿病患者使用胰高血糖素样肽-1受体激动剂和钠-葡萄糖协同转运蛋白2抑制剂的情况：基于全国登记的队列研究
Carl-Emil Lim,Björn Pasternak,Björn Eliasson et al.
Carl-Emil Lim et al.
Background: GLP-1 receptor agonists and SGLT2 inhibitors improve cardiometabolic risk factors in type 1 diabetes, but lack approval, partly due to safety concerns. We aimed to assess the use of these drugs in a national p...